Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.890
+0.040 (1.40%)
Apr 9, 2026, 11:14 AM EDT - Market open
LIXT Market Cap
LIXT has a market cap or net worth of $33.58 million as of April 9, 2026. Its market cap has increased by 832.66% in one year.
Market Cap
33.58M
Enterprise Value
29.04M
1-Year Change
832.66%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $33.58M, a decrease of -29.16%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 33.10M | 47.77% |
| Dec 31, 2025 | 22.40M | 386.96% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 26.94M |
| Serina Therapeutics | 26.48M |
| Boundless Bio | 26.44M |
| Lexaria Bioscience | 26.38M |
| Daré Bioscience | 26.35M |
| IGC Pharma | 25.69M |
| Exicure | 25.62M |
| Skye Bioscience | 23.85M |